ImmunityBio IBRX
NASDAQ IBRX
$8.22 -0.09 (-1.08%)
At close: Oct 23, 2026 · 4:00 PM EDT

ImmunityBio (IBRX) Sale and Maturity of Investments (2015 - 2026)

Updated

Analysis

ImmunityBio (IBRX) Sale and Maturity of Investments (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 ImmunityBio 8.66 Bn 7.42 Bn 50.94 Mn 60.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.29 Mn
Mar 31, 2026 119.23 Mn
Dec 31, 2025 90.47 Mn
Mar 31, 2025 5.35 Mn
Dec 31, 2024 18.03 Mn
Sep 30, 2024 69.57 Mn
Jun 30, 2024 35.00 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 10.37 Mn
Mar 31, 2023 102,000.00
Dec 31, 2022 56,000.00
Sep 30, 2022 14.85 Mn
Jun 30, 2022 132.75 Mn
Mar 31, 2022 14.35 Mn
Dec 31, 2021 11.60 Mn
Sep 30, 2021 599,000.00
Jun 30, 2021 18.71 Mn
Mar 31, 2021 39.02 Mn
Dec 31, 2020 14.65 Mn
Sep 30, 2020 -21.60 Mn
API Access

ImmunityBio Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=IBRX&period=max&api_key=YOUR_API_KEY